Viewing StudyNCT00146744



Ignite Creation Date: 2024-05-05 @ 11:49 AM
Last Modification Date: 2024-10-26 @ 9:14 AM
Study NCT ID: NCT00146744
Status: COMPLETED
Last Update Posted: 2017-05-30
First Post: 2005-09-06

Brief Title: Safety and Immunogenicity of GSK Biologicals Candidate Tuberculosis Vaccine Mtb72FAS02A in Healthy PPD-positive Adults
Sponsor: GlaxoSmithKline
Organization: GlaxoSmithKline

Key Dates - Follows AllAPIJSON File Order

Start Date: 2005-07
Start Date Type: None
Primary Completion Date: 2006-05
Primary Completion Date Type: ACTUAL
Completion Date: 2006-05
Completion Date Type: ACTUAL
First Submit Date: 2005-09-06
First Submit QC Date: September 6 2005
Study First Post Date: 2005-09-07
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2017-05-24
Last Update Post Date: 2017-05-30
Last Update Post Date Type: ACTUAL